ArticleDiscover oncology2025

TRIM44 facilitates aggressive behaviors in multiple myeloma through promoting ZEB1 deubiquitination.

Hui Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.